Ezetimibe/simvastatin 10/40 mg versus atorvastatin 40 mg in high cardiovascular risk patients with primary hypercholesterolemia: a randomized, double-blind, active-controlled, multicenter study

BACKGROUND: A considerable number of patients with severely elevated LDL-C do not achieve recommended treatment targets, despite treatment with statins. Adults at high cardiovascular risk with hypercholesterolemia and LDL-C ≥ 2.59 and ≤ 4.14 mmol/L (N = 250), pretreated with atorvastatin 20 mg were...

Descripción completa

Detalles Bibliográficos
Autores principales: Hing Ling, Paul Kah, Civeira, Fernando, Dan, Andrei Gheorghe, Hanson, Mary E, Massaad, Rachid, De Tilleghem, Celine Le Bailly, Milardo, Christopher, Triscari, Joseph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3306831/
https://www.ncbi.nlm.nih.gov/pubmed/22293030
http://dx.doi.org/10.1186/1476-511X-11-18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3306831/
https://www.ncbi.nlm.nih.gov/pubmed/22293030
http://dx.doi.org/10.1186/1476-511X-11-18

Ejemplares similares